Dynavax Technologies Corporation
DVAX
$9.99
-$0.31-3.01%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 31.17% | 25.85% | -27.85% | -48.10% | -66.24% |
| Total Other Revenue | -50.83% | -53.57% | -26.45% | 35.12% | 70.19% |
| Total Revenue | 24.76% | 19.36% | -27.79% | -45.65% | -63.98% |
| Cost of Revenue | 18.83% | 5.64% | -19.98% | -42.27% | -58.57% |
| Gross Profit | 29.00% | 30.19% | -31.85% | -47.66% | -67.06% |
| SG&A Expenses | 12.53% | 4.89% | 11.33% | 13.09% | 10.82% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.94% | 5.18% | -2.76% | -16.94% | -32.47% |
| Operating Income | 94.62% | 102.93% | -107.13% | -108.59% | -107.71% |
| Income Before Tax | -807.11% | 806.57% | -61.31% | -83.52% | -96.70% |
| Income Tax Expenses | 431.90% | 75.42% | 152.02% | -28.29% | -177.89% |
| Earnings from Continuing Operations | -751.37% | 527.44% | -66.50% | -84.48% | -96.09% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -751.37% | 527.44% | -66.50% | -84.48% | -96.09% |
| EBIT | 94.62% | 102.93% | -107.13% | -108.59% | -107.71% |
| EBITDA | 121.15% | 121.14% | -101.79% | -105.33% | -106.00% |
| EPS Basic | -783.24% | 510.39% | -67.40% | -84.76% | -96.12% |
| Normalized Basic EPS | 267.95% | 647.41% | -77.98% | -89.10% | -97.58% |
| EPS Diluted | -1,009.22% | 382.62% | -65.88% | -84.35% | -96.32% |
| Normalized Diluted EPS | 360.20% | 386.45% | -78.71% | -90.03% | -98.25% |
| Average Basic Shares Outstanding | -0.45% | 1.03% | 1.66% | 1.62% | 1.63% |
| Average Diluted Shares Outstanding | 3.05% | 4.40% | -2.26% | -1.92% | -1.94% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |